Waggoner Lab

35.5K posts

Waggoner Lab

Waggoner Lab

@LabWaggoner

Research lab of Dr. Stephen Waggoner. Opinions expressed are Dr. Waggoner's alone and not on behalf of lab staff or employer. @labwaggoner.bsky.social

Cincinnati, OH Sumali Ağustos 2018
7.7K Sinusundan12.3K Mga Tagasunod
Waggoner Lab nag-retweet
Dr. Priyam Bordoloi
Dr. Priyam Bordoloi@DocPriyamMD·
Misinformation truly will be the end of the world. Dr. Paul Thomas didn't lose his license for "finding the truth"...he lost it for negligence. He advised against the Tetanus vaccine for a child who later contracted the infection and required mechanical ventilation for weeks. And this study was retracted for a reason: it used a fabricated metric (RIOV) and was riddled with selection bias.
Liz Churchill@liz_churchill10

“I published a study proving that vaccinated children were 500% more ill…and then I got a call from my attorney saying that my licence was suspended” Dr. Paul Thomas studied more than 3,000 children and proved that unvaccinated children were healthier than vaccinated children.

English
30
561
4.7K
115.4K
Waggoner Lab nag-retweet
Long Lab
Long Lab@longlabstanford·
The first approved GLP1 (Byetta) came from a desert reptile, the Gila monster. Inspired by this, our work on Burmese pythons 🐍🐍 is now out @NatMetabolism. An “extreme”-ly fun collaboration with Leinwand and @DrYongXu1. Congratulations @Shuke_Xiao! nature.com/articles/s4225…
English
4
25
74
4.3K
Waggoner Lab nag-retweet
Michal Tal, PhD
Michal Tal, PhD@ImmunoFever·
Th2 responses are more prevalent than we think, and cause more harm than we think
Icahn School of Medicine at Mount Sinai@IcahnMountSinai

A new study from the Icahn School of Medicine at Mount Sinai reveals that major depressive disorder may share key immune abnormalities with inflammatory skin diseases—opening the door to new, targeted treatment strategies. Researchers identified overlap in the Th2 immune pathway, a mechanism well known in conditions like atopic dermatitis, and found that targeting this pathway could offer a novel, personalized approach to treating depression. The findings also highlight the potential of repurposing existing immunology therapies to address psychiatric conditions. “Given the successful translational approach in dermatology, we brought together experts across psychiatry, dermatology, and neuroscience to assess whether a targeted treatment strategy could work in major depressive disorder,” says James Murrough, MD, PhD. Read more mshs.co/3PbENpb

English
3
9
41
5.7K

Tuklasin

@CellReports @EinsteinMed @MaryanovichLab @KLabUmass @UMassAmherst @Gujarlab @CellCellPress @Harvard